Susan Elizabeth Shoaf
Clinical Pharmacology
Otsuka Pharmaceutical Development & Commercialization
Inc., Rockville
MD 20850
USA
Name/email consistency: high
- Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide. Shoaf, S.E., Bramer, S.L., Bricmont, P., Zimmer, C.A. J. Cardiovasc. Pharmacol. (2007)
- Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias. Shoaf, S.E., Elizari, M.V., Wang, Z., Sekar, K., Grinfeld, L.R., Barbagelata, N.A., Lerman, J., Bramer, S.L., Trongé, J., Orlandi, C. J. Cardiovasc. Pharmacol. Ther. (2005)